Members |
targetComponentId |
[X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Agents primarily affecting water-balance and mineral and uric acid metabolism causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Air and space transport accidents |
Extension Namespace {1000000} (namespace concept) |
[X]Airway disease due to other specific organic dusts |
Extension Namespace {1000000} (namespace concept) |
[X]Alcohol deterrents causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Allergic contact dermatitis due to other agents |
Extension Namespace {1000000} (namespace concept) |
[X]Allergic contact dermatitis due to other chemical products |
Extension Namespace {1000000} (namespace concept) |
[X]Alpha-adrenoreceptor antagonists causing adverse effects in therapeutic use, not elsewhere classified |
Extension Namespace {1000000} (namespace concept) |
[X]Amebiasis, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Amebic infection of other sites |
Extension Namespace {1000000} (namespace concept) |
[X]Aminoglycosides causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Amputation of limb(s) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure |
Extension Namespace {1000000} (namespace concept) |
[X]Analeptics causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Androgens and anabolic congeners causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Anemia (nonmegaloblastic) associated with other specified nutritional deficiencies |
Extension Namespace {1000000} (namespace concept) |
[X]Anemia in other chronic diseases classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Anesthesiology devices associated with adverse incidents |
Extension Namespace {1000000} (namespace concept) |
[X]Anesthesiology devices associated with adverse incidents, diagnostic and monitoring devices |
Extension Namespace {1000000} (namespace concept) |
[X]Anesthesiology devices associated with adverse incidents, miscellaneous devices, not elsewhere classified |
Extension Namespace {1000000} (namespace concept) |
[X]Anesthesiology devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices |
Extension Namespace {1000000} (namespace concept) |
[X]Anesthesiology devices associated with adverse incidents, surgical instruments, materials and devices (including sutures) |
Extension Namespace {1000000} (namespace concept) |
[X]Anesthesiology devices associated with adverse incidents, therapeutic (nonsurgical) and rehabilitative devices |
Extension Namespace {1000000} (namespace concept) |
[X]Anesthetics and therapeutic gases causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Aneurysm of aorta in diseases classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Aneurysm of other specified arteries |
Extension Namespace {1000000} (namespace concept) |
[X]Angiotensin II receptor antagonists causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Angiotensin-converting-enzyme inhibitors causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Animal-rider or occupant of animal-drawn vehicle injured in transport accident |
Extension Namespace {1000000} (namespace concept) |
[X]Anogenital herpes viral infection, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Anomalies of pupillary function in diseases classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Antenatal screening for fetal growth retardation using ultrasonics and other physical methods |
Extension Namespace {1000000} (namespace concept) |
[X]Antenatal screening for malformations using ultrasonics and other physical methods |
Extension Namespace {1000000} (namespace concept) |
[X]Anthrax, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Anti-common-cold drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antiallergic and antiemetic drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antiasthmatics causing adverse effects in therapeutic use, not elsewhere classified |
Extension Namespace {1000000} (namespace concept) |
[X]Anticholinesterase agents causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Anticoagulants causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antidiarrheal drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antidotes and chelating agents causing adverse effects in therapeutic use, not elsewhere classified |
Extension Namespace {1000000} (namespace concept) |
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antigonadotrophins, antiestrogens, antiandrogens causing adverse effects in therapeutic use, not elsewhere classified |
Extension Namespace {1000000} (namespace concept) |
[X]Antihelminthics causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antihyperlipidemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antimycobacterial drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antineoplastic antimetabolites causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antineoplastic natural products causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antiparkinsonism drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antipruritics causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antirheumatics causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antispasticity drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antithyroid drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antitussives causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Antiviral drugs causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Anxiety disorder, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Aortic aneurysm of unspecified site, nonruptured |
Extension Namespace {1000000} (namespace concept) |
[X]Aortic aneurysm of unspecified site, ruptured |
Extension Namespace {1000000} (namespace concept) |
[X]Aortic valve disorders in diseases classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Aortitis in diseases classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Aplastic and other anemias |
Extension Namespace {1000000} (namespace concept) |
[X]Apocrine sweat disorder, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Apocrine sweat disorder, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Appetite depressants [anorectics] causing adverse effects in therapeutic use |
Extension Namespace {1000000} (namespace concept) |
[X]Arenaviral hemorrhagic fever, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Arthritis and polyarthritis due to other specified bacterial agents |
Extension Namespace {1000000} (namespace concept) |
[X]Arthritis in other infectious and parasitic diseases classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Arthropathies in other endocrine, nutritional and metabolic disorders |
Extension Namespace {1000000} (namespace concept) |
[X]Arthropathies in other specified diseases classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Arthropathy in hypersensitivity reactions classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Arthropathy in neoplastic disease classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Arthropathy in other blood disorders classified elsewhere |
Extension Namespace {1000000} (namespace concept) |
[X]Arthropod-borne viral encephalitis, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Arthropod-borne viral fevers and viral hemorrhagic fevers |
Extension Namespace {1000000} (namespace concept) |
[X]Arthrosis |
Extension Namespace {1000000} (namespace concept) |
[X]Ascariasis with other complications |
Extension Namespace {1000000} (namespace concept) |
[X]Ascariasis, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Ascariasis, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Aspergillosis, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Aspergillosis, unspecified |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence at home |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence at industrial and construction area |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence at other specified place |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence at school, other institution and public administrative area |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence at sports and athletics area |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence at trade and service area |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence at unspecified place |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence in residential institution |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence on farm |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by blunt object, occurrence on street and highway |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by bodily force |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by bodily force, occurrence at home |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by bodily force, occurrence at industrial and construction area |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by bodily force, occurrence at other specified place |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by bodily force, occurrence at school, other institution and public administrative area |
Extension Namespace {1000000} (namespace concept) |
[X]Assault by bodily force, occurrence at sports and athletics area |
Extension Namespace {1000000} (namespace concept) |